Matthew Spencer George - 16 Mar 2026 Form 4 Insider Report for Merlin, Inc. (BACQ)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: BACQ
Reported as of: 16 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Mar 2026, 17:06:27 UTC
Next SEC filing: 22 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Leslie Renee Ravestein, Attorney-in-Fact

Key filing fact

Matthew Spencer George filed Form 4 for Merlin, Inc. (BACQ) on 18 Mar 2026.

Key facts

This page summarizes Matthew Spencer George's Form 4 filing for Merlin, Inc. (BACQ).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Mar 2026, 17:06.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002117604 Primary reporting owner

George Matthew Spencer

Relationship: Chief Executive Officer, Director
Address: C/O MERLIN, INC., 129 SOUTH STREET, BOSTON
Signature: /s/ Leslie Renee Ravestein, Attorney-in-Fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BACQ transaction

Common Stock

Award

Transaction value
Shares: +14,890,622
Change %
Price
Shares after: 14,890,622
Date: 16 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BACQ transaction Derivative

Stock Option

Award

Transaction value
Shares: +1,512,485
Change %
Price
Shares after: 1,512,485
Date: 16 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,512,485
Exercise price: $8.48
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents securities received as part of the Issuer's business combination, in connection with the Business Combination Agreement, dated as of August 13, 2025, by and among the Issuer (formerly known as Inflection Point Acquisition Corp. IV), IPDX Merger Sub, Inc., a direct wholly owned subsidiary of the Issuer, and Merlin Labs, Inc. ("Legacy Merlin"), pursuant to which the common stock of Legacy Merlin automatically converted into newly issued shares of Common Stock. In addition, each Legacy Merlin stock option was automatically converted into the right to receive stock options of the Issuer with the same terms and conditions.

Footnote F2

The stock option will vest in full on February 4, 2027.